Abstract
Resistin is a recently discovered hormone that is exclusively expressed in adipose tissue. Its expression in rodents was reported to be elevated or suppressed in genetic and diet-induced obesity, respectively. Resistin treatment impaired glucose tolerance and insulin action. Immunoneutralization of resistin improved insulin sensitivity, while thiazolidinedione treatment reduced resistin expression. Therefore, resistin could play a critical role in the development of obesity and type 2 diabetes. In this study were determined resistin plasma levels in humans suffering from type 1 and type 2 diabetes and in healthy controls. Plasma levels of resistin in healthy controls were 38.78 ng/ml. They were not statistically different in individuals with a broad BMI range. Resistin plasma levels in type 2 diabetes were 38.7 ng/ml, and 39.4 ng/ml in type 1 diabetes. Thiazolidinedione treatment did not influence resistin plasma levels. We conclude from our data: 1. resistin can be detected in human plasma, 2. plasma resistin levels are not different in type 1 and type 2 diabetes.
Key words
Resistin - Diabetes - Insulin Resistance - Adipose Tissue
References
-
1
Steppan C M, Bailey S T, Bhat S, Brown E J, Banerjee R R, Wright C M, Patel H R, Ahima R S, Lazar M A.
The hormone resistin links obesity to diabetes.
Nature.
2001;
409
307-312
-
2
Steppan C M, Brown E J, Wright C M, Bhat S, Banerjee R R, Dai C Y, Enders G H, Silberg D G, Wen X, Wu G D, Lazar M A.
A family of tissue-specific resistin-like molecules.
Proc Natl Acad Sci USA.
2001;
98
502-506
-
3
Banerjee R R, Lazar M A.
Dimerization of resistin and resistin-like molecules is determined by a single cysteine.
J Biol Chem .
2001;
276
25 970-25 973
-
4
Holcomb I N, Kabakoff R C, Chan B, Baker T W, Gurney A, Henzel W, Nelson C, Lowman H B, Wright B D, Skelton N J, Frantz G D, Tumas D B, Peale F V, Shelton D L, Hebert C C.
FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family.
Embo J.
2000;
19
4046-4055
-
5
Ling C, Kindblom J, Wennbo H, Illig H.
Increased resistin expression in the adipose tissue of male prolactin transgenic mice and in male mice with elevated androgen levels.
FEBS Lett.
2001;
507
147-150
-
6
Levy J R, Davenport B, Clore J N, Stevens W.
Lipid metabolism and resistin gene expression in insulin-resistant Fischer 344 rats.
Am J Physiol Endocrinol Metab.
2002;
282
E626-633
-
7
Juan C C, Au L C, Fang V S, Kang S F, Ko Y H, Kuo S F, Hsu Y P, Kwok C F, Ho L T.
Suppressed gene expression of adipocyte resistin in an insulin-resistant model probably by elevated free fatty acids.
Biochem Biophys Res Comm.
2001;
289
1328-1333
-
8
LeLay S, Boucher J, Rey A, Castan-Laurell I, Krief S, Ferre P, Valet P, Dugail I.
Decreased resistin expression in mice with different sensitivities to a high-fat diet.
Biochem Biophys Res Comm.
2001;
289
564-567
-
9
Way J M, Gorgun C Z, Tong Q, Uysal K T, Brown K K, Harrington W W, Oliver W R, Willson T M, Kliewer S A, Hotamisligil G S.
Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists.
J Biol Chem.
2001;
276
25 651-25 653
-
10
Moore G B, Chapman H, Holder J C, Lister C A, Piercy V, Smith S A, Chapham J C.
Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice.
Biochem Biophys Res Comm.
2001;
286
741-745
-
11
Nagaev I, Smith U.
Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle.
Biochem Biophys Res Comm.
2001;
285
561-564
-
12
McTernan C L, McTernan P G, Harte A L, Levick P L, Marnett A H, Kumar S.
Resistin, central obesity, and type 2 diabetes (Letter).
Lancet.
2002;
359
46-47
-
13
McTernan P G, McTernan C L, Chetty R, Jenner K, Fisher F M, Lauer M N, Crocker J, Barnett A H, Kumar S.
Increased resistin gene and protein expression in human abdominal adipose tissue.
J Clin Endocrinol Metab.
2002;
87
2407
-
14
Savage D B, Sewter C P, Klenk E S, Segal D G, Vidal-Pluig A M, Considine R V, O'Rahilly S.
Resistin/fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans.
Diabetes.
2001;
50
2199-2202
-
15
Janke J, Engeli S, Gorzelniak K, Luft F C, Sharma A M.
Resistin gene expression in human adipocytes is not related to insulin resistance.
Obesity Res.
2002;
10
1-5
-
16
Do M S, Nam S Y, Hong S E, Kim K W, Duncan J S, Beattle J H, Trayhurn P.
Metallothionein gene expression in human adipose tissue from lean and obese subjects.
Horm Metab Res.
2002;
34
348-351
-
17
Engeli S, Sharma A M.
Role of adipose tissue for cardiovascular-renal regulation in health and disease.
Horm Metab Res.
2000;
32
485-499
-
18
Bruun J M, Pedersen S B, Richelsen B.
Interleukin-8 production in human adipose tissue. Inhibitory effects of anti-diabetic compounds, the thiazolidinedione ciglitazone and the biguanid metformin.
Horm Metab Res.
2000;
32
537-541
-
19
Kim K H, Lee K, Moon Y S, Sul H S.
A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation.
J Biol Chem.
2001;
276
11 252-11 256
-
20
Cao H, Hegele R A.
Single nucleotide polymorphisms of the resistin (RSTN) gene.
J Hum Genet.
2001;
46
553-555
-
21
Engert J C, Vohl M C, Williams S M, Lepage P, Loredo-Osti J C, Faith J, Dore C, Renaud Y, Burtt N P, Villeneuve A, Hirschhorn J N, Altshuler D, Groop L C, Despres J P, Gaudet D, Hudson T J.
5′ flanking variants of resistin are associated with obesity.
Diabetes.
2002;
51
1629-1634
-
22
Osawa H, Onuma H, Murakami A, Ochi M, Nishimiya T, Kata K, Shimizu I, Fujii Y, Ohashi J, Makino H.
Systematic search for single nucleotide polymorphisms in the resistin gene: the absence of evidence for the association of three identified single nucleotide polymorphisms with Japanese type 2 diabetes.
Diabetes.
2002;
51
863-866
-
23
Sentinelli F, Romeo S, Arca M, Filippi E, Leonetti F, Banchieri M, DiMario U, Baroni M G.
Human resistin gene, obesity, and type 2 diabetes: mutation analysis and population study.
Diabetes.
2002;
51
860-862
PD Dr. H.-C. Fehmann
Practice for Internal Medicine
Großseelheimer Str. 28 · 35039 Marburg · Germany
Telefon: + 49 (64 21) 48 58 58
Fax: + 49 (64 21) 48 58 59
eMail: C.Fehmann@web.de
